Global Women's Health Academy

What to Know About PARP Inhibitors for Advanced Ovarian Cancer

ReachMD Healthcare Image

Learn about PARP inhibitors for advanced ovarian cancer, including their mechanism of action, efficacy, safety, and more.

  • Overview

    The treatment landscape for advanced ovarian cancer has changed recently with the addition of PARP inhibitors, which have been shown to prolong patients’ progression-free survival. Discover more about this treatment option, like its mechanism of action, efficacy, and safety, with Dr. Charles Turck and Dr. Joshua Kesterson, Medical Director of the Gynecologic Oncology Program at UPMC in central Pennsylvania.

Facebook Comments


We’re glad to see you’re enjoying Global Women's Health Academy…
but how about a more personalized experience?

Register for free